Clinical Theragnostic Potential of Diverse miRNA Expressions in Prostate Cancer: A Systematic Review and Meta-Analysis
<i>Background:</i> Prostate cancer (PrC) is the second-most frequent cancer in men, its incidence is emerging globally and is the fifth leading cause of death worldwide. While diagnosis and prognosis of PrC have been studied well, the associated therapeutic biomarkers have not yet been i...
Main Authors: | Rama Jayaraj, Greg Raymond, Sunil Krishnan, Katherine S. Tzou, Siddhartha Baxi, M. Ravishankar Ram, Suresh Kumar Govind, Harish C. Chandramoorthy, Faisal N. Abu-Khzam, Peter Shaw |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/5/1199 |
Similar Items
-
Clinical Theragnostic Relationship between Drug-Resistance Specific miRNA Expressions, Chemotherapeutic Resistance, and Sensitivity in Breast Cancer: A Systematic Review and Meta-Analysis
by: Rama Jayaraj, et al.
Published: (2019-10-01) -
Theragnostic Aspects and Radioimmunotherapy in Pediatric Tumors
by: Andrea Cimini, et al.
Published: (2020-05-01) -
From the Magic Bullet to Theragnostics: Certitudes and Hypotheses, Trying to Optimize the Somatostatin Model
by: Giuseppe Danilo Di Stasio, et al.
Published: (2021-07-01) -
Radiotherapy and inhibition of the EGF family as treatment strategies for prostate cancer: combining theragnostics with theragates
by: Wolfgang Lilleby, et al.
Published: (2011-06-01) -
miRNA Predictors of Pancreatic Cancer Chemotherapeutic Response: A Systematic Review and Meta-Analysis
by: Madhav Madurantakam Royam, et al.
Published: (2019-06-01)